Biography
Toykan leads operations and customer success at Massive Bio, building robust processes and dedicated support systems that ensure patients and partners receive exceptional service throughout their journey. He is passionate about removing friction points in the patient experience and fostering long-term relationships with healthcare providers. He drives operational excellence while keeping patient outcomes at the center of every decision.
What Are Myeloproliferative Neoplasms?
MARCH 2022
Polycythemia Vera and Myelofibrosis
MARCH 2022
What Are the Treatment Options For Follicular Lymphoma?
MARCH 2022
Living and Managing Tips When You Have Myelofibrosis
MARCH 2022
What Are the Differences Between Solid and Liquid Tumors?
FEBRUARY 2022
Mantle cell lymphoma clinical trials
FEBRUARY 2022
Immunotherapy for Non-Hodgkin Lymphoma
JANUARY 2022
Non Small Cell Lung Cancer Treatment
MAY 2021
NTRK Fusion-Positive Cancers
MARCH 2021
Drugs Used to Treat Myelofibrosis & Treatments – Massive Bio
MARCH 2021
Massive Bio Selected in Top 100 Cancer Blogs
MARCH 2021
Dr. Selin Kurnaz Startup Success with Panwar – Massive Bio
JANUARY 2021
Myelofibrosis Clinical Trials
JANUARY 2021
Massive Bio Recognized as a Top Cancer Startup
JANUARY 2021
Does Sugar Feed Cancer? – Should I stop consuming sugar?
NOVEMBER 2020
Massive Bio CEO Joins When She Founded
SEPTEMBER 2020
What Is Usually the First Sign of Lung Cancer?
SEPTEMBER 2020
Stage 4 Cervical Cancer Clinical Trials
MAY 2020
Machine Learning and AI in Drug Research and Development-177 Startups
DECEMBER 2019
The Burden of Caregiving
SEPTEMBER 2019
ACCC 44th Cancer Center Business Summit – Massive Bio
MARCH 2018
Digital Health Company
APRIL 2017
No articles match your search.